Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I.
Autoinmune polyendocrinopathy.
Fernández Miró M, Colom Comí C, Godoy Lorenzo R.
Med Clin (Barc). 2021 Sep 10;157(5):241-246. doi: 10.1016/j.medcli.2021.02.004. Epub 2021 May 3.
Impaired salivary gland activity in patients with autoimmune polyendocrine syndrome type I.
Oftedal BE, Marthinussen MC, Erichsen MM, Tveitarås MK, Kjellesvik-Kristiansen A, Hammenfors D, Jonsson MV, Kisand K, Jonsson R, Wolff ASB.
Autoimmunity. 2017 Jun;50(4):211-222. doi: 10.1080/08916934.2017.1344972. Epub 2017 Jul 7.
Autoimmune polyendocrine syndromes associated with autoimmune rheumatic diseases.
Jankowska K, Dudek P, Stasiek M, Suchta K.
Reumatologia. 2023;61(4):225-238. doi: 10.5114/reum/170266. Epub 2023 Aug 31.
Autoimmune polyendocrine syndrome induced by immune checkpoint inhibitors: a systematic review.
Zhao Z, Wang X, Bao XQ, Ning J, Shang M, Zhang D.
Cancer Immunol Immunother. 2021 Jun;70(6):1527-1540. doi: 10.1007/s00262-020-02699-1. Epub 2020 Nov 16.
[Type 1 diabetes and autoimmune polyendocrine syndromes].
Queiroz MS.
Arq Bras Endocrinol Metabol. 2008 Mar;52(2):198-204. doi: 10.1590/s0004-27302008000200007.
[Autoimmune polyendocrine syndrome (APS)].
Warzée E, Legros JJ, Geenen V.
Rev Med Liege. 2002 Nov;57(11):710-4.
[Autoimmune polyendocrine syndrome in adults. Focus on rheumatological aspects of the problem: A review].
Panevin TS, Zotkin EG, Troshina EA.
Ter Arkh. 2023 Nov 23;95(10):881-887. doi: 10.26442/00403660.2023.10.202484.
The IVIG treatment response in autoimmune polyendocrine syndromes type 2 with anti-GAD65 antibody-associated stiff person syndrome: a case report and literature review.
Yang Y, Jiang H, Yang W, Wang H, Wang M, Li X, Huang P, Fang S, Hao W, Yang Y, Zhao F, He W.
Front Immunol. 2025 Jan 7;15:1471115. doi: 10.3389/fimmu.2024.1471115. eCollection 2024.
Autoimmune polyendocrine syndrome type 2 in children: a case report and literature review.
Liu Y, Wang F, Zhang L, Zhang H, Zhu Y.
BMC Pediatr. 2025 May 2;25(1):351. doi: 10.1186/s12887-025-05697-3.
Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
Alimohammadi M, Björklund P, Hallgren A, Pöntynen N, Szinnai G, Shikama N, Keller MP, Ekwall O, Kinkel SA, Husebye ES, Gustafsson J, Rorsman F, Peltonen L, Betterle C, Perheentupa J, Akerström G, Westin G, Scott HS, Holländer GA, Kämpe O.
N Engl J Med. 2008 Mar 6;358(10):1018-28. doi: 10.1056/NEJMoa0706487.
